Skip to main content
NIH funding notice RFA-NS-20-010

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Closed on September 8, 2022.

Posted
October 4, 2019
Close date
September 8, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
6
4 new, 2 renewals
Median first-year cost
$375,993
$3,702,248 in all
Institutions
5
5 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. ZETROZ SYSTEMS, LLC2
  2. 2MORROW, INC1
  3. EVON MEDICS, LLC1
  4. HILLMED INC1
  5. THERMAQUIL, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZRG1 ETTN-A (13))2
  2. Special Emphasis Panel (ZRG1 ETTN-C (10))2
  3. Special Emphasis Panel (ZRG1 ETTN-S (14))1
  4. Special Emphasis Panel (ZRG1 NV-G (13))1
6 awards under RFA-NS-20-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain2R44MD015912-03Lewis, George KennethZETROZ SYSTEMS, LLC, CTFirst-year cost $1,482,405Study section ZRG1
FY2022Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)1R44NS125745-01A1Nwaokobia, Charles ChieduNwulia, Evaristus AEVON MEDICS, LLC, MDFirst-year cost $499,999Study section ZRG1
FY2021Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches2R44NS115460-02Popielarski, StephenYuan, HsiangkuoTHERMAQUIL, INC., PAFirst-year cost $998,122Study section ZRG1
FY2021HEAL - Development and implementation of a provider prescribed, behavioral digital therapeutic designed to support, educate, screen and remotely monitor patients with chronic pain1R44AT011593-01Masterson, JoWaters, Deanna2MORROW, INC, WAFirst-year cost $251,986Study section ZRG1
FY2021An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management1R44HD107822-01Dias, NicholasHILLMED INC, TXFirst-year cost $251,964Study section ZRG1
FY2020Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain1R43MD015912-01Lewis, George KennethZETROZ SYSTEMS, LLC, CTFirst-year cost $217,772Study section ZRG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.2.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-NS-20-010: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | ScienceDex | ConductScience